2010 Oct;35(10):1575-87
Animal research has examined its potential to accelerate tissue repair, promote angiogenesis (new blood vessel formation), reduce localized inflammation, support gut and ulcer healing, and enhance tendon and ligament recovery
Funding Statement The authors are supported by grants from the National Institute of Health (NIH/NCCIH)-(5R33AT010637-01A1 and 3R33 AT010637-02S1) and the Malcolm Feist Endowed Chair in Diabetes
Hence, there is a need for fine-tuned engineering strategies that not only improve pharmacokinetic properties, but also enhance specific effector functions with a minimum of amino acid substitutions to reduce the risk of immunogenicity
The starting dose of 0.3 mg represents approximately 6.7% of the final maintenance dosea conservative approach that prioritizes safety
(12) Overproduction of RONS can tip the oxidant to antioxidant balance, thereby destroying cell membranes, proteins, and DNA